|
Castro, Patricia; Xia, Chen; Gomez, Lori et al. (2004) Interleukin-8 expression is increased in senescent prostatic epithelial cells and promotes the development of benign prostatic hyperplasia. Prostate 60:153-9
|
|
Polnaszek, Nathaniel; Kwabi-Addo, Bernard; Wang, Jianghua et al. (2004) FGF17 is an autocrine prostatic epithelial growth factor and is upregulated in benign prostatic hyperplasia. Prostate 60:18-24
|
|
Castro, Patricia; Giri, Dipak; Lamb, Dolores et al. (2003) Cellular senescence in the pathogenesis of benign prostatic hyperplasia. Prostate 55:30-8
|
|
Giri, D; Ozen, M; Ittmann, M (2001) Interleukin-6 is an autocrine growth factor in human prostate cancer. Am J Pathol 159:2159-65
|
|
Giri, D; Ittmann, M (2001) Interleukin-8 is a paracrine inducer of fibroblast growth factor 2, a stromal and epithelial growth factor in benign prostatic hyperplasia. Am J Pathol 159:139-47
|
|
Giri, D; Ittmann, M (2000) Interleukin-1alpha is a paracrine inducer of FGF7, a key epithelial growth factor in benign prostatic hyperplasia. Am J Pathol 157:249-55
|
|
Giri, D; Ropiquet, F; Ittmann, M (1999) Alterations in expression of basic fibroblast growth factor (FGF) 2 and its receptor FGFR-1 in human prostate cancer. Clin Cancer Res 5:1063-71
|
|
Ropiquet, F; Giri, D; Lamb, D J et al. (1999) FGF7 and FGF2 are increased in benign prostatic hyperplasia and are associated with increased proliferation. J Urol 162:595-9
|
|
Giri, D; Ropiquet, F; Ittmann, M (1999) FGF9 is an autocrine and paracrine prostatic growth factor expressed by prostatic stromal cells. J Cell Physiol 180:53-60
|
